docetaxel anhydrous has been researched along with p5091 in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (p5091) | Trials (p5091) | Recent Studies (post-2010) (p5091) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 24 | 0 | 23 |
| Protein | Taxonomy | docetaxel anhydrous (IC50) | p5091 (IC50) |
|---|---|---|---|
| Ubiquitin carboxyl-terminal hydrolase 7 | Homo sapiens (human) | 4.2 | |
| Ubiquitin carboxyl-terminal hydrolase 47 | Homo sapiens (human) | 4.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, T; Fu, Y; Gao, Y; Li, X; Liu, Y; Peng, Y; Qi, X; Yin, L; Yuan, B; Zhang, S; Zhu, Q | 1 |
1 other study(ies) available for docetaxel anhydrous and p5091
| Article | Year |
|---|---|
USP7 is a novel Deubiquitinase sustaining PLK1 protein stability and regulating chromosome alignment in mitosis.
Topics: Apoptosis; Cell Cycle Proteins; Chromosomes; Chromosomes, Human; Docetaxel; Drug Resistance, Neoplasm; G2 Phase Cell Cycle Checkpoints; HEK293 Cells; Humans; M Phase Cell Cycle Checkpoints; Male; Mitosis; Nasopharyngeal Neoplasms; Polo-Like Kinase 1; Prostatic Neoplasms; Protease Inhibitors; Protein Serine-Threonine Kinases; Protein Stability; Proto-Oncogene Proteins; Signal Transduction; Thiophenes; Transfection; Ubiquitin-Specific Peptidase 7 | 2019 |